In the News...Does insulin use differ by gender? Diabetes & Covid update, fully implantable CGM studied, and more!
It's In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: A new study looks at insulin needs in men vs women, updates on stem cell transplants and a new ...
19 Heinä 20249min
What is EPI? The link to diabetes (and whether you're at risk)
DIY Pioneer Dana Lewis was diagnosed with something called EPI – exocrine pancreatic insufficiency a couple of years ago. She'd never heard of it and was shocked to find out diabetes is considered a c...
10 Heinä 202440min
In the News... Generic GLP-1, All-in-one sensor and infusion set, 365-day CGM and more!
It's In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: The Eversense CGM could soon be approved for one year of continuous use, the first generic GLP-...
5 Heinä 20249min
What to do when you can't fill your Ozempic or Mounjaro prescription - Advice from an endocrinologist
Medications like Ozempic and Mounjaro have fundamentally changed the way diabetes is treated. But even if your doctor writes the prescription and your insurance company covers it, getting your hands o...
26 Kesä 202427min
In the news.. Insulin pen shortage, Omnipod 5 update, once-weekly insulin approved in Canada, and more!
It's In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: South Africa runs out of insulin pens - and why this could happen anywhere, once-weekly insulin...
21 Kesä 20247min
What is a diabetologist (and should you see one?)
Have you heard of a diabetologist? This is a newer specialty in the U-S that may help offset the lack of endocrinologists. Most people with type 2 see a general practitioner and the diabetology certif...
12 Kesä 202433min
In the News... Dexcom to Apple Watch, Metformin during pregnancy, Mounjaro shortage update... and more!
It's In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: Dexcom goes Direct to Watch in the US, Abbott gets FDA okay for its OTC CGM, new study about me...
7 Kesä 202410min
Transforming Diabetes Care: GlucosePATH Makes Personalized Medication Recommendations
GlucosePATH uses computer science and clinical data to evaluate every possible treatment option, using data from the patient, FDA, and peer-reviewed journals, in just a few seconds. It was created by ...
29 Touko 202435min
